Full Court hears government’s $325M fight with Sanofi over ban on Plavix generic

Acting Justice Arthur Emmett 2021-02-16 4:13 pm By Miklos Bolza | Sydney

Please login to bookmark

Pharmaceutical companies Sanofi and Bristol-Myers Squibb are liable for losses to the federal government for excess subsidies it allegedly paid for the blood-thinner Plavix after an unjustified court injunction prevented the release of a generic version of the top-selling drug, an appeals court has heard.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au